According to Marksans Pharma 's latest financial reports the company's current earnings (TTM) are A$82.7 M. In 2023 the company made an earning of A$78.5 M an increase over its 2022 earnings that were of A$55.23 M.The earnings displayed on this page is the company's Pretax Income.